ONYX PHARMACEUTICALS INC Revenue
ONYX PHARMACEUTICALS INC reported Revenue of $153.03 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC revenues for the quarter ending 2013-06-30 was $153.03M, a 110.48% increase year-over-year.
- ONYX PHARMACEUTICALS INC revenues for the quarter ending 2013-03-31 was $145.49M, a 101.99% increase year-over-year.
- ONYX PHARMACEUTICALS INC revenues for the quarter ending 2012-12-31 was $127.92M, a 46.03% decline year-over-year.
- ONYX PHARMACEUTICALS INC revenues for the quarter ending 2012-09-30 was $89.51M, a 19.28% increase year-over-year.
- ONYX PHARMACEUTICALS INC revenues for fiscal 2012 was $362.17M, a 19.01% decline from fiscal 2011.
- ONYX PHARMACEUTICALS INC revenues for fiscal 2011 was $447.17M, a 37.80% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC revenues for fiscal 2010 was $324.51M, a 29.09% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC revenues for fiscal 2009 was $251.39M, a 29.35% increase from fiscal 2008.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2013-06-30 | $153.03M 10-Q · filed 2013-08-09 | $298.52M 10-Q · filed 2013-08-09 | $426.44M derived: sum of 3 quarters · filed 2013-08-09 | $515.95M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $145.49M 10-Q · filed 2013-05-08 | $273.41M derived: sum of 2 quarters · filed 2013-05-08 | $362.92M derived: sum of 3 quarters · filed 2013-05-08 | $435.63M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $127.92M 10-K · filed 2013-02-28 | $217.43M derived: sum of 2 quarters · filed 2013-02-28 | $290.13M derived: sum of 3 quarters · filed 2013-08-09 | $362.17M 10-K · filed 2013-02-28 |
| 2012-09-30 | $89.51M 10-K · filed 2013-02-28 | $162.22M derived: sum of 2 quarters · filed 2013-08-09 | $234.25M 10-Q · filed 2012-11-02 | $471.28M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $72.70M 10-Q · filed 2013-08-09 | $144.74M 10-Q · filed 2013-08-09 | $381.77M derived: sum of 3 quarters · filed 2013-08-09 | $456.81M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $72.03M 10-Q · filed 2013-05-08 | $309.06M derived: sum of 2 quarters · filed 2013-05-08 | $384.10M derived: sum of 3 quarters · filed 2013-05-08 | $452.06M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $237.03M 10-K · filed 2013-02-28 | $312.07M derived: sum of 2 quarters · filed 2013-02-28 | $380.03M derived: sum of 3 quarters · filed 2013-02-28 | $447.17M 10-K · filed 2013-02-28 |
| 2011-09-30 | $75.04M 10-K · filed 2013-02-28 | $143.00M derived: sum of 2 quarters · filed 2013-02-28 | $210.14M 10-Q · filed 2012-11-02 | $280.12M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $67.96M 10-K · filed 2013-02-28 | $135.10M 10-Q · filed 2012-08-06 | $205.08M derived: sum of 3 quarters · filed 2013-02-28 | $327.94M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $67.14M 10-K · filed 2013-02-28 | $137.12M derived: sum of 2 quarters · filed 2013-02-28 | $259.98M derived: sum of 3 quarters · filed 2013-02-28 | $328.76M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $69.98M 10-K · filed 2012-02-27 | $192.84M derived: sum of 2 quarters · filed 2012-02-27 | $261.61M derived: sum of 3 quarters · filed 2012-02-27 | $324.51M 10-K · filed 2013-02-28 |
| 2010-09-30 | $122.86M 10-K · filed 2012-02-27 | $191.63M derived: sum of 2 quarters · filed 2012-02-27 | $254.54M 10-Q · filed 2011-11-03 | $322.85M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $68.77M 10-K · filed 2012-02-27 | $131.68M 10-Q · filed 2011-08-09 | $199.99M derived: sum of 3 quarters · filed 2012-02-27 | $269.13M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $62.90M 10-K · filed 2012-02-27 | $131.22M derived: sum of 2 quarters · filed 2012-02-27 | $200.36M derived: sum of 3 quarters · filed 2012-02-27 | $260.57M derived: sum of 4 quarters · filed 2012-02-27 |
| 2009-12-31 | $68.32M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $137.45M derived: sum of 2 quarters · filed 2012-02-27 | $197.67M derived: sum of 3 quarters · filed 2012-02-27 | $251.39M 10-K · filed 2012-02-27 |
| 2009-09-30 | $69.14M 10-Q · filed 2010-11-03 | $129.36M derived: sum of 2 quarters · filed 2010-11-03 | $183.07M 10-Q · filed 2010-11-03 | |
| 2009-06-30 | $60.22M 10-Q · filed 2010-08-04 | $113.94M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $194.34M 10-K · filed 2011-02-23 |